Chemodex

Magnolol

CHF 68.00
In stock
CDX-M0170-M01010 mgCHF 68.00
More Information
Product Details
Synonyms 5,5'-Diallyl-2,2'-biphenyldiol; NSC 293099
Product Type Chemical
Properties
Formula C18H18O2
MW 266.33
CAS 528-43-8
RTECS DV5105500
Purity Chemicals ≥98% (HPLC)
Appearance White to off-white powder.
Solubility Soluble in ethanol (1mg/ml), methanol (1mg/ml), DMSO (10mg/ml) or DMF (10mg/ml). Insoluble in water.
Identity Determined by 1H-NMR.
Declaration Manufactured by Chemodex.
Other Product Data

Click here for Original Manufacturer Product Datasheet
Our product description may differ slightly from the original manufacturers product datasheet.

InChi Key VVOAZFWZEDHOOU-UHFFFAOYSA-N
Smiles OC1=CC=C(CC=C)C=C1C2=CC(CC=C)=CC=C2O
Shipping and Handling
Shipping AMBIENT
Short Term Storage +4°C
Long Term Storage +4°C
Handling Advice Protect from light and moisture.
Use/Stability Stable for at least 2 years after receipt when stored at +4°C.
Documents
MSDS Inquire
Product Specification Sheet
Datasheet Download PDF
Description

Magnolol is a bioactive compound isolated from the bark of M. officinalis that has been used in Asian traditional medicine for the treatment of anxiety, sleep disorders, and allergic diseases. Magnolol is an antifungal, antibacterial and antioxidant compound. It demonstrates anti-inflammatory activity by interferring with NF-κB signalling and NLRP3 inhibition. Magnolol can activate cannabinoid (CB) receptors, behaving as a partial agonist with selectivity for the peripheral CB2 subtype versus central CB1. It been identified as modulators of the GABAA receptors in vitro. It is a potent antitumor and antiangiogenic compound. Shown to inhibit HIF-1α/VEGF signalling, inhibiting invasion and metastasis through MMP2/MMP9 and inhibiting microtubule polymerization. Induces apoptosis through EGFR/PI3K/Akt pathway. Shows anti-diabetic/anti-obesity activity targeting nuclear receptors retinoic X receptor α (RXRα) and peroxisome proliferator activated receptor γ (PPARγ). In addition promotes thermogenesis.

Product References

(1) K. Watanabe, et al.; Planta Med. 49, 103 (1983) | (2) J.P. Wang, et al.; Naunyn Schmiedebergs Arch. Pharmacol. 346, 707 (1992) | (3) Y. Maruyama, et al.; J. Nat. Prod. 61, 135 (1998) | (4) K.H. Bang, et al.; Arch. Pharm. Res. 23, 46 (2000) | (5) K.Y. Ho, et al.; Phytother. Res. 15, 139 (2001) | (6) J. Ai, et al.; Pharmacology 63, 34 (2001) | (7) K. Ikeda & H. Nagase; Biol. Pharm. Bull. 25, 1546 (2002) | (8) K. Ikeda, et al.; Phytother. Res. 17, 933 (2003) | (9) J. Park, et al.; Eur. J. Pharmacol. 496, 189 (2004) | (10) A.K. Tse, et al.; Mol. Immunol. 44, 2647 (2007) | (11) D.H. Lee, et al.; J. Cell Biochem. 106, 1113 (2009) | (12) E.S. Hwang & K.K. Park; Biosci. Biotechnol. Biochem. 74, 961 (2010) | (13) H. Zhang, et al.; PLoS One 6, e28253 (2011) | (14) V. Rempel, et al.; ACS Med. Chem. Lett. 4, 41 (2013) | (15) M.C. Chen, et al.; Biochem. Pharmacol. 85, 1278 (2013) | (16) Y. Sakaue, et al.; Microbiol. Immunol. 60, 10 (2016) | (17) J. Shen, et al.; Cell Physiol. Biochem. 42, 1789 (2017) | (18) F. Huang, et al.; Mol. Med. Rep. 16, 4817 (2017) | (19) H.A. Parray, et al.; Nutrition 50, 82 (2018)

© 2017 Adipogen Life Sciences. Pictures: © 2012 Martin Oeggerli. All Rights Reserved.